multi-center study and compared to radical nephrectomy (RN) performed in the same centers for tumors of comparable diameter and VTT. Demographics, perioperative complications, functional, and oncologic outcomes were compared between the two groups. Mean, median, standard deviation, and interquartile range (IQR) were used to report continuous variables, as appropriate. Survival analysis were used to assess recurrence free survival (RFS), cancer specific survival (CSS) and overall survival (OS). Univariable (UVA) and multivariable (MVA) analyses were used to evaluate variables predicting complications, OS, CSS and RFS, and end-stage renal disease (ESRD, eGFR<30).
INTRODUCTION AND OBJECTIVES: Nearly half of all patients undergoing partial nephrectomy (PNx) for cT1 tumors will have adverse final pathologic features such as high Fuhrman grade or pT3a disease. While renal mass biopsy can aid in the identification of high grade disease, tools to predict tumor upstaging are limited. Given that preoperative risk factors associated with pT3a upstaging are not well defined we sought to identify predictors of pT3a disease in patients undergoing PNx for cT1 disease.
METHODS: A retrospective chart review was completed to identify patients with cT1 renal masses who underwent open or minimally-invasive PNx between 2000-2014. All patients with imaging sufficient for R.E.N.A.L Nephrometry scoring were included. The primary outcome was upstaging to pT3a disease at final pathology. All patients with benign final pathology were excluded. Univariate and multivariate logistic regression analyses were performed to identify characteristics independently associated with pT3a upstaging. All variables with a pvalue of 0.1 on univariate analysis were included in the multivariate analysis.
RESULTS: A total of 508 patients were identified, of which 449 (88%) had final pT1 and 59 (12%) had final pT3a disease. The etiology of pT3a upstaging was perinephric adipose extension in 69% (41/59), renal sinus fat invasion in 28% (14/59), and microscopic segmental or renal vein invasion in 7% (4/59). Patient age (p¼0.012), ASA classification (p¼0.005), preoperative radiologic tumor size (p¼0.079), and high R.E.N.A.L Nephrometry Score complexity (p¼0.017) were all associated with pT3a upstaging on univariate analysis. Multivariate analysis demonstrated a significant and independent association of patient age (p¼0.025), preoperative radiologic tumor size (p¼0.014), and high R.E.N.A.L Nephrometry Score complexity (p¼0.019) with pT3a upstaging.
CONCLUSIONS: In patients who undergo PNx for cT1 disease, patient age, preoperative radiologic tumor size, and high R.E.N.A.L Nephrometry Score complexity represent readily measurable preoperative characteristics that are associated with increased risk of pT3a upstaging. The presence of these features may be utilized for operative planning to ensure adequate resection and negative margins in patients at increased risk for pathologic upstaging. Because studies are limited due to the rarity of this variant, we reviewed our experience with ccRCC and report on long term oncologic outcomes of cystic ccRCC. METHODS: We identified 3,865 patients treated with radical or partial nephrectomy for unilateral, sporadic ccRCC between 1970 and 2010. One urologic pathologist re-reviewed all pathologic slides, blinded to patient outcome. Cancer-specific survival (CSS) was estimated using the Kaplan-Meier method and compared between those with and without cystic ccRCC using log-rank tests.
Source of Funding: None
RESULTS: Overall, 158 of 3,865 (4%) patients had cystic ccRCC. Compared to patients with non-cystic ccRCC, patients with cystic ccRCC were younger (median 58 vs. 63 years, p<0.001), were more likely to have radiographic evidence of cystic structures (60% vs. 17%, p<0.001), were less likely to have distant metastases at surgery (0% vs. 14%, p<0.001), and had smaller tumors (median 3.0 vs. 6.0cm, p<0.001) that were less likely to contain coagulative tumor necrosis (1% vs. 29%, p<0.001) or sarcomatoid differentiation (0% vs. 5%, p¼0.006). With a median follow-up for survivors of 10.5 years (IQR 7.3-14.9), 63 patients with cystic ccRCC died at a median of 7.7 years after surgery (IQR 3.8-11.9). However, only one patient died from RCC after developing metastases 22 years after the initial surgery. CSS rates at 25 years following surgery were significantly better for cystic ccRCC compared to non-cystic ccRCC (88% vs. 52%, p<0.001) (Figure 1) , even among the subset of pT1, pNX/0, M0 patients (100% vs. 83%, p¼0.001).
CONCLUSIONS: In a large cohort of ccRCC patients with pathologic re-review and long-term follow-up, our results suggest that cystic ccRCC is both uncommon and associated with a very favorable prognosis. INTRODUCTION AND OBJECTIVES: Complex cystic masses pose a clinical challenge given lack of certainty for malignant potential. Cystic changes are common in renal cell carcinoma (RCC); however, there is limited data on cystic RCC (cRCC) specifically. The Bosniak classification system is used to categorize these lesions and help predict risk of malignancy. Current literature suggests that cRCC has a more favorable and benign course, but with no consensus on proper diagnosis and intervention. We aim to better categorize cRCC and the natural history of this disease.
METHODS: We identified all patients with pathologically confirmed cRCC, multilocular cRCC, or RCC with cystic features between Jan 2000 -Dec 2015 from our institutional database. Patients with follow-up of <1 year, previous history of RCC, familial syndromes, multifocal tumors, and lesions with >50% solid component on imaging were excluded from our analysis. Available imaging was re-reviewed by a single expert radiologist (AH). Radiological, clinical, and pathological characteristics were recorded. RESULTS: Of 128 patients identified for analysis, 76 (59.4%) were male and 52 (40.6%) were female. Median age at surgery was 54.4 years (17.3-78.4). Twenty (15.6%) patients had a family history of RCC. The majority of lesions were found incidentally on imaging (89.1%). Fourteen (10.9%) patients had local symptoms, with flank pain (8.6%) being the most common. Partial nephrectomy was performed on 116 (90.6%) patients and radical nephrectomy on 12 (9.4%); open technique was used in >80% of cases. Pathologic and imaging characteristics are shown in Table 1 . On median follow-up of 66.1 months, there were no tumor recurrences or metastatic disease. A total of 5 (3.9%) patients died from other conditions. CONCLUSIONS: Diagnosis of cRCC should include cystic lesions with <50% solid component on imaging. Our data shows that cRCC includes a wide variety of tumors, most commonly with clear cell features. Most of these lesions are discovered incidentally on imaging as Bosniak grades 3 or 4 and are surgically resected. These patients uniformly do well with minimal risk of recurrence or metastasis on follow-up, thus, nephron sparing surgery is recommended. Given the indolent nature cRCC, enrollment of these patients into active surveillance protocols should be considered. 
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INTRODUCTION AND OBJECTIVES:
It is recommended to remove suspect cystic renal tumours when they are classified as Bosniak 3. These masses are fragile and may rupture during dissection or tumour excision. The impact of this intraoperative spillage on oncological outcomes remains uncertain. The objective of this study was to assess incidence of intraoperative cystic rupture according to surgical approach and its impact on oncological outcomes. METHODS: Between 2005 and 2015, patients who had a partial nephrectomy (PN) in height European centres have been retrospectively analysed. We specifically sought if there was a cystic spillage during the procedure. Oncological outcomes included overall survival (OS), disease specific survival (DSS) and recurrence-free survival (RFS). We performed a sub-group analysis on surgical approach (open partial nephrectomy (OPN) vs. robot-assisted partial nephrectomy (RAPN)) and on the existence of intraoperative cystic spillage (ICS) to determine their impact on oncological outcomes. Kaplan-Meier curves of RFS were produced. A multivariate analysis with logistic regression model was used to assess predictors of intraoperative cystic spillage. RESULTS: Overall, 268 patients were included. Malignancy of cystic renal masses was found in 75% of cases. Among them, 84.5% were Bosniak IV, 68% were Bosniak III and 62.5% were Bosniak IIF on preoperative CT-scan. With a mean follow-up of 32 months, OS was 95.1%, only 2% had a local recurrence, metastatic progression was found in 2% of cases and there was no specific-disease death. We reported intraoperative cystic spillage (ICS) in 18.7% (n¼50) of cases (20% during RAPN vs. 18% during OPN). Among them, 77.5% were
